The dual test: Safeguarding p-value combination tests for adaptive designs

Statistics in Medicine

Volumn 29, Issue 7-8, 2010, Pages 797-807

  Burman, Carl Fredrik ^a   Lisovskaja, Vera ^b  

^a ASTRAZENECA R AND D   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Clinical trial; Conditional power; Decision analysis; Flexible design; Sample size reestimation

Indexed keywords

ANALYTICAL ERROR; ARTICLE; HYPOTHESIS; NORMAL DISTRIBUTION; SAMPLE SIZE; STATISTICAL SIGNIFICANCE;

BAYES THEOREM; BIOSTATISTICS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DRUG APPROVAL; HUMANS; SAMPLE SIZE;

EID: 77949349495     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.3704     Document Type: Article

References (31)

1. Dragalin V. Adaptive designs: terminology and classification. Drug Information Journal 2006; 40:425-435.
2. Bauer P, Köhne K. Evaluation of experiments with adaptive interim analyses. Biometrics 1994; 50:1029-1041.
3. Burman C-F, Sonesson C. Are flexible designs sound? (with Discussion). Biometrics 2006; 62:664-683.
4. Denne JS. Sample size recalculation using conditional power. Statistics in Medicine 2001; 20:2645-2660.
5. Wald A. Sequential Analysis. Wiley: New York, 1947.
6. Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64:191-199.
7. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979; 35:549-556.
8. Jennison C, Turnbull BW. Group Sequential Tests with Applications to Clinical Trials. Chapman & Hall, CRC: Boca Raton, 2000.
9. Zelen M. Play the winner rule and the controlled clinical trial. Journal of the American Statistical Association 1969; 64:131-146.
10. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975; 31:103-115.
11. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70:659-663.
12. Proschan MA, Hunsberger SA. Designed extension of studies based on conditional power. Biometrics 1995; 51:1315-1324.
13. Fisher LD. Self-designing clinical trials. Statistics in Medicine 1998; 17:1551-1562.
14. Lehmacher W, Wassmer G. Adaptive sample size calculations in group sequential trials. Biometrics 1999; 55:1286-1290.
15. Müller H-H, Schäfer H. Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and classical group sequential approaches. Biometrics 2001; 57:886-891.
16. Bauer P, Kieser M. Combining different phases in the development of medical treatments within a single trial. Statistics in Medicine 1999; 18:1833-1848.
17. European Medicines Agency. Reflection Paper on Methodological Issues in Confirmatory Clinical Trials with Flexible Design and Analysis Plan. European Medicines Agency: London, 2006. Available from: www.emea.europa.eu/ pdfs/human/ewp/245902en.pdf [accessed October 2008].
18. Bauer P, Koenig F. The reassessment of trial perspectives from interim data-a critical view. Statistics in Medicine 2006; 25:23-36.
19. Brannath W, Posch M, Bauer P. Recursive combination tests. Journal of the American Statistical Association 2002; 97:236-244.
20. Posch M, König F, Branson M, Brannath W, Dunger-Baldauf C, Bauer P. Testing and estimation in flexible group sequential designs with adaptive treatment selection. Statistics in Medicine 2005; 24:3697-3714.
21. Bretz F, Schmidli H, König F, Racine A, Maurer W. Confirmatory seamless phase II/ III clinical trials with hypotheses selection at interim: general concepts. Biometrical Journal 2006; 48:623-634.
22. Chen YHJ, DeMets DL, Lan KKG. Increasing the sample size when the unblinded interim result is promising. Statistics in Medicine 2004; 23:1023-1038.
23. Posch M, Bauer P, Brannath W. Issues in designing flexible trials. Statistics in Medicine 2003; 22:953-969.
24. Wong KW, Lisovskaja V. The dual test: an alternative test for an adaptive design with sample size re-estimation. MSc Thesis, Department of Mathematical Sciences, Chalmers University of Technology and Göteborg University, Göteborg, Sweden, 2008.
25. Brannath W, König F, Bauer P. Estimation in flexible two stage designs. Statistics in Medicine 2006; 25:3366-3381.
26. Lehmann EL, Romano JP. Testing Statistical Hypotheses (3rd edn). Springer: New York, 2005.
27. Shen Y, Fisher LD. Statistical inference for self-designing clinical trials with a one-sided hypothesis. Biometrics 1999; 55:190-197.
28. Proschan MA, Liu Q, Hunsberger SA. Practical midcourse sample size modification in clinical trials. Controlled Clinical Trials 2003; 24:4-15.
29. Gittins J, Pezeshk H. A behavioral Bayes method for determining the size of a clinical trial. Drug Information Journal 2000; 34:355-363.
30. Thach CT, Fisher LD. Self-designing two-stage trials to minimize expected costs. Biometrics 2002; 58:432-438.
31. Mehta CR, Patel NR. Adaptive, group sequential and decision theoretic approaches to sample size determination. Statistics in Medicine 2006; 25:3250-3269.